- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Endometriosis
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 1.3MB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 537KB)
Relugolix with estradiol and with norethisterone acetate – March 2024
Relugolix with Estradiol and with Norethisterone Acetate:Tablet containing relugolix 40 mg with estradiol (as hemihydrate) 1 mg and with norethisterone acetate 0.5 mg; Ryeqo®
Last updated
30 May 2025